Product Information
IRBESARTAN 150 MG TABLET is a generic product labeled by Hisun Pharmaceuticals USA Inc., priced at $0.1109 per EA under NDC 42658012204. Its NADAC has been published 365 times since Aug 28, 2019.
FDA first approved this application on Jun 14, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Hisun Pharmaceuticals USA Inc.NDC
42658012204
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206194FDA Approved
6/14/2016
TE Code
AB
On Market Since
4/15/2017
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 365 times since Aug 28, 2019, and over the history we have for it it has declined 59.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1109 per EA |
|---|---|
| All-time high | $0.3249 (Oct 16, 2019) |
| All-time low | $0.0990 (Nov 20, 2024) |
| 52-week high | $0.1186 |
| 52-week low | $0.1103 |
| Median price | $0.1592 |
| Average price | $0.1793 |
| Largest weekly change | +25.9% (Jun 19, 2024) |
| Weeks tracked | 365 |
| Tracking since | Aug 28, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by Hisun Pharmaceuticals USA Inc., is $0.1109 per EA (NDC 42658012204), effective Aug 19, 2026.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 59.6%. It has been tracked across 365 weekly CMS publications since Aug 28, 2019.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Aug 28, 2019, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.0990 (Nov 20, 2024) to a high of $0.3249 (Oct 16, 2019), with a median of $0.1592 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IRBESARTAN 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 42658012204) is labeled by Hisun Pharmaceuticals USA Inc., and CMS classifies it as a generic product.